Egypt approves Sputnik V COVID-19 vaccine
25 February 2021 | News
Egyptian Drug Authority has approved the vaccine under the emergency use authorisation procedure
Source credit: Shutterstock
The Russian Direct Investment Fund (RDIF) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Egyptian Drug Authority.
Egypt is the 35th country in the world to approve Sputnik V. It is also the most populated country in the Middle-East with over 100 million people.
Egyptian Drug Authority has approved the vaccine under the emergency use authorisation procedure.
Kirill Dmitriev, CEO, Russian Direct Investment Fund, said, “Egypt is the most populated country of the Middle-East and the decision of the Egyptian Drug Authority to include Sputnik V in the national vaccine portfolio demonstrates the appreciation of safety and efficacy of the vaccine. Sputnik V is now approved in 35 countries around the world and the number of registrations will keep increasing in coming weeks as the Russian vaccine is widely recognised as one of the best in the world.”
